Aspect Biosystems develops bioprinted tissue therapeutics to treat serious metabolic and endocrine diseases using AI-powered bioprinting technology.

Ionomr Innovations specializes in developing advanced ion-exchange membranes and polymers for clean energy applications such as fuel cells, hydrogen production, and carbon capture.